Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
- Joseph Biederman
- , Suma Krishnan
- , Yuxin Zhang
- , James J. McGough
- , Robert L. Findling
Research output: Contribution to journal › Article › peer-review
238
Scopus
citations